Search results

Non-titrated quality control human citrated plasma for coagulation assays. Dilution plasma for the assay of lupus anticoagulant (LA) with usual laboratory methods.

For any in vitro protocol or research study where a source of human fibrinogen deficient plasma is required.

Coagulation assays, such as the Activated Partial Thromboplastin Time (APTT) or for the assays of factors of the intrinsic coagulation pathway.

Coagulation assays, such as the activated partial thromboplastin time (aPTT) or for the assays of factors of the intrinsic coagulation pathway.

Reagent with low phospholipid concentration for confirming the presence of lupus anticoagulants (LA). The presence of LA does not or only insignificantly prolong clotting time.

Calibration of a modified one-stage FVIII activity assay for determination of active emicizumab concentration from a clot time measurement performed on an automated coagulation analyzer.

Intended for use as a deficient substrate in clot-based factor VIII activity assays using the one-stage activated partial thromboplastin time (aPTT) method.

Intended for use as a deficient substrate in clot-based factor VIII activity assays using the one-stage activated partial thromboplastin time (aPTT) method.

Quality control of a modified one-stage FVIII activity assay for determination of active emicizumab concentration from a clot time measurement performed on an automated coagulation analyzer.

Assay proposed for the measurement of heparin in research applications.